The Cigna Group (CI): Oversold on the Charts, Solid in the Fundamentals

The Cigna Group (NYSE:CI) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds.

The company reported solid earnings in the first quarter of 2025, with revenues of $65.4 billion, up 14.3% growth from the same period last year. The revenue also beat analysts’ estimates by $5.07 billion. The company reported shareholders’ net income of $1.3 billion, which translates to $4.85 per share. Adjusted income from operations for the same period was $1.8 billion, or $6.74 per share.

The Cigna Group (NYSE:CI) reported that it is developing a more sustainable healthcare model by effectively fulfilling its commitments and initiatives aimed at enhancing transparency and providing better support for customers and patients. Its strong performance in the first quarter, along with an upgraded full-year earnings outlook, highlights the robustness of its Evernorth Health Services and Cigna Healthcare growth platforms amid a dynamic market environment.

In addition to this, The Cigna Group (NYSE:CI) is also a prominent dividend payer. The company currently pays a quarterly dividend of $1.51 per share, having raised it by 7.9% in January. Through this increase, CI stretched its dividend growth streak to five years. The stock has a dividend yield of 2.04%, as of July 25.

While we acknowledge the potential of CI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 14 Stocks That Paid Special Dividends in 2025 and Dividend Champions vs Aristocrats: 12 Under-the-Radar Stocks to Buy

Disclosure: None.